Skip Nav Destination
Targeting BCL-2 in B-cell lymphomas
A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review
Issue Archive
Table of Contents
INSIDE BLOOD COMMENTARIES
PERSPECTIVE
Targeting BCL-2 in B-cell lymphomas
Clinical Trials & Observations
BLOOD SPOTLIGHT
CLINICAL TRIALS AND OBSERVATIONS
A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy
Clinical Trials & Observations
Zhangyuan Kong,Ping Qin,Shan Xiao,Hai Zhou,Hong Li,Renchi Yang,Xiaofan Liu,Jianmin Luo,Zhichun Li,Guochao Ji,Zhongguang Cui,Yusheng Bai,Yuxia Wu,Linlin Shao,Jun Peng,Jun Ma,Ming Hou
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review
Clinical Trials & Observations
LYMPHOID NEOPLASIA
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma
Tomoko Narita,Takashi Ishida,Asahi Ito,Ayako Masaki,Shiori Kinoshita,Susumu Suzuki,Hisashi Takino,Takashi Yoshida,Masaki Ri,Shigeru Kusumoto,Hirokazu Komatsu,Kazunori Imada,Yuetsu Tanaka,Akifumi Takaori-Kondo,Hiroshi Inagaki,Arne Scholz,Philip Lienau,Taruho Kuroda,Ryuzo Ueda,Shinsuke Iida
MYELOID NEOPLASIA
PLATELETS AND THROMBOPOIESIS
Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis
Kellie R. Machlus,Stephen K. Wu,Prakrith Vijey,Thomas S. Soussou,Zhi-Jian Liu,Eran Shacham,T. J. Unger,Trinayan Kashyap,Boris Klebanov,Martha Sola-Visner,Marsha Crochiere,Joseph E. Italiano, Jr,Yosef Landesman
RED CELLS, IRON, AND ERYTHROPOIESIS
TRANSPLANTATION
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
Lori Muffly,Marcelo C. Pasquini,Michael Martens,Ruta Brazauskas,Xiaochun Zhu,Kehinde Adekola,Mahmoud Aljurf,Karen K. Ballen,Ashish Bajel,Frederic Baron,Minoo Battiwalla,Amer Beitinjaneh,Jean-Yves Cahn,Mathew Carabasi,Yi-Bin Chen,Saurabh Chhabra,Stefan Ciurea,Edward Copelan,Anita D’Souza,John Edwards,James Foran,Cesar O. Freytes,Henry C. Fung,Robert Peter Gale,Sergio Giralt,Shahrukh K. Hashmi,Gerhard C. Hildebrandt,Vincent Ho,Ann Jakubowski,Hillard Lazarus,Marlise R. Luskin,Rodrigo Martino,Richard Maziarz,Philip McCarthy,Taiga Nishihori,Rebecca Olin,Richard F. Olsson,Attaphol Pawarode,Edward Peres,Andrew R. Rezvani,David Rizzieri,Bipin N. Savani,Harry C. Schouten,Mitchell Sabloff,Matthew Seftel,Sachiko Seo,Mohamed L. Sorror,Jeff Szer,Baldeep M. Wirk,William A. Wood,Andrew Artz
LETTERS TO BLOOD
BLOOD WORK
-
Cover Image
Cover Image
![issue cover]()
Platelets treated with selinexor retain cytoskeletal integrity (β-tubulin, green; F-actin, red), which suggests that selinexor-induced thrombocytopenia is not caused by aberrant platelet activation. See the article by Machlus et al on page 1132.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
